Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O.
Charlier C, et al.
J Antimicrob Chemother. 2006 Mar;57(3):384-410. doi: 10.1093/jac/dki473. Epub 2006 Jan 31.
J Antimicrob Chemother. 2006.
PMID: 16449304
Review.
Fluconazole is still a major drug for antifungal prophylaxis in the setting of transplantation (solid organ and bone marrow), intensive care unit, and in neutropenic patients. Prophylactic fluconazole still has a place in HIV-positive patients in viro-immunological failure …
Fluconazole is still a major drug for antifungal prophylaxis in the setting of transplantation (solid organ and bone marrow), intensive c …